Literature DB >> 13820205

Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies.

J L EMMETT, L F GREENE, A PAPANTONIOU.   

Abstract

Entities:  

Keywords:  CARCINOMA/therapy; CASTRATION; ESTROGENS/therapy; PROSTATE/neoplasms

Mesh：

Substances：

Year:  1960        PMID： 13820205     DOI： 10.1016/s0022-5347(17)65741-0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  Total perineal prostatectomy for carcinoma. Indications and results.

Authors:  M J Feeney; R B Mullenix; R J Prentiss; G E Howe
Journal:  Calif Med       Date:  1967-05

Review 2.  Current concepts in the management of carcinoma of the prostate gland.

Authors:  E M Meares
Journal:  Calif Med       Date:  1972-12

3.  Cytologic aspects of diseases of the prostate.

Authors:  P Faul; E Schmiedt
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

4.  The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.

Authors:  J Flamm; J Spona
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

5.  Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

Authors:  D Kerle; G Williams; H Ware; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

Review 6.  Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.

Authors:  L G Crowley; S A Duwe
Journal:  Calif Med       Date:  1969-02

7.  Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells.

Authors:  Takashi Otsuka; Aki Hamada; Kazuhiro Iguchi; Shigeyuki Usui; Kazuyuki Hirano
Journal:  Biomed Rep       Date:  2013-05-17

8.  Prognostic significance of cytological differentiation grading in estrogen-treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy. (Five-year follow-up of 496 patients).

Authors:  P Faul; E Schmiedt; R Kern
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

Review 9.  Primary hormone therapy for locally advanced prostate cancer.

Authors:  Gregory P Swanson
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 2.862
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.